GPER functions as a tumor suppressor in triple-negative breast cancer cells

The Correlation between GPR30 and Clinicopathologic Variables in Breast Carcinomas

(2014) Gang Tu et al.   TECHNOLOGY IN CANCER RESEARCH & TREATMENT

GPER-1 Expression Decreases During Breast Cancer Tumorigenesis

(2013) Tanja Ignatov et al.   CANCER INVESTIGATION

Selective GPER activation decreases proliferation and activates apoptosis in tumor Leydig cells

(2013) A Chimento et al.   Cell Death & Disease

The G-protein-coupled estrogen receptor agonist G-1 suppresses proliferation of ovarian cancer cells by blocking tubulin polymerization

(2013) C Wang et al.   Cell Death & Disease

GPER-1 acts as a tumor suppressor in ovarian cancer

(2013) Tanja Ignatov et al.   Journal of Ovarian Research

Inactivation of GPR30 reduces growth of triple-negative breast cancer cells: possible application in targeted therapy

(2012) Rainer Girgert et al.   BREAST CANCER RESEARCH AND TREATMENT

GPR30 regulates the EGFR-Akt cascade and predicts lower survival in patients with ovarian cancer

(2012) Satoe Fujiwara et al.   Journal of Ovarian Research

Functional Mechanisms for Human Tumor Suppressors

(2012) Wanpeng Sun et al.   Journal of Cancer

G-protein-coupled estrogen receptor GPR30 and tamoxifen resistance in breast cancer

(2011) Atanas Ignatov et al.   BREAST CANCER RESEARCH AND TREATMENT

GPR30 Activation Opposes Estrogen-Dependent Uterine Growth via Inhibition of Stromal ERK1/2 and Estrogen Receptor Alpha (ERα) Phosphorylation Signals

(2011) Fei Gao et al.   ENDOCRINOLOGY

The GPER1 Agonist G-1 Attenuates Endothelial Cell Proliferation by Inhibiting DNA Synthesis and Accumulating Cells in the S and G2 Phases of the Cell Cycle

(2011) Anders Holm et al.   JOURNAL OF VASCULAR RESEARCH

Role of Cyclin B1/Cdc2 Up-Regulation in the Development of Mitotic Prometaphase Arrest in Human Breast Cancer Cells Treated with Nocodazole

(2011) Hye Joung Choi et al.   PLoS One

Role of GPR30 in endometrial pathology after tamoxifen for breast cancer

(2010) Tanja Ignatov et al.   AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY

The G Protein-Coupled Receptor GPR30 Inhibits Proliferation of Estrogen Receptor-Positive Breast Cancer Cells

(2010) E. A. Ariazi et al.   CANCER RESEARCH

Activation of GPR30 inhibits the growth of prostate cancer cells through sustained activation of Erk1/2, c-jun/c-fos-dependent upregulation of p21 and induction of G2 cell-cycle arrest

(2010) Q K Y Chan et al.   CELL DEATH AND DIFFERENTIATION

Role of GPR30 in the mechanisms of tamoxifen resistance in breast cancer MCF-7 cells

(2009) Atanas Ignatov et al.   BREAST CANCER RESEARCH AND TREATMENT

GPR30 and estrogen receptor expression: new insights into hormone dependence of inflammatory breast cancer

(2009) Hugo Arias-Pulido et al.   BREAST CANCER RESEARCH AND TREATMENT

Mutant p53 mediates survival of breast cancer cells

(2009) L Y Lim et al.   BRITISH JOURNAL OF CANCER

APC promoter hypermethylation is an early event in endometrial tumorigenesis

(2009) Atanas Ignatov et al.   CANCER SCIENCE

An essential role for p73 in regulating mitotic cell death

(2009) W H Toh et al.   CELL DEATH AND DIFFERENTIATION

Mechanisms of Resistance to Structurally Diverse Antiestrogens Differ under Premenopausal and Postmenopausal Conditions: Evidence fromin VitroBreast Cancer Cell Models

(2009) Ping Fan et al.   ENDOCRINOLOGY

GPR30 predicts poor survival for ovarian cancer

(2009) Harriet O. Smith et al.   GYNECOLOGIC ONCOLOGY

Human Chorionic Gonadotropin Attracts Regulatory T Cells into the Fetal-Maternal Interface during Early Human Pregnancy

(2009) A. Schumacher et al.   JOURNAL OF IMMUNOLOGY

In vivo effects of a GPR30 antagonist

(2009) Megan K Dennis et al.   Nature Chemical Biology

Estrogen Signaling through the Transmembrane G Protein–Coupled Receptor GPR30

(2008) Eric R. Prossnitz et al.   Annual Review of Physiology

Triple-Negative Breast Cancer: Risk Factors to Potential Targets

(2008) B. P. Schneider et al.   CLINICAL CANCER RESEARCH

Epidermal Growth Factor Induces G Protein-Coupled Receptor 30 Expression in Estrogen Receptor-Negative Breast Cancer Cells

(2008) Lidia Albanito et al.   ENDOCRINOLOGY

P16 alterations increase the metastatic potential of endometrial carcinoma

(2008) Atanas Ignatov et al.   GYNECOLOGIC ONCOLOGY